Searched for
CDMOS
Nifty stuck in a range but small and midcaps are where real money is being made: Ashish ChaturmohtaIndian stock markets may appear stagnant, but opportunities exist in small and midcap stocks. JM Financial's Ashish Chaturmohta highlights ...- Two separate venues for pharma industry expos in Delhi-NCRCPHI India and PMEC India are expanding their pharmaceutical expos to two venues in Delhi-NCR. This move aims to support the rapid growth o...
- Trump tariffs hit patented drugs: Jefferies, Nomura explain impact on pharma stocksThe US has slapped up to 100% tariffs on patented drugs, sparing generics and biosimilars but exposing India’s speciality pharma players. S...
- War, falling markets, and a two-year window: Why Vikas Khemani is buying banks, aviation, and pharma right nowIndian markets are down, presenting a buying opportunity for long-term investors. Vikas Khemani of Carnelian Asset Management sees potentia...
- Health makes wealth, says Equirus, as healthcare fundraising crosses pre-Covid high of Rs 62,432 croreIndia’s healthcare and life sciences sector has surpassed its Covid-era fundraising peak, with inflows crossing Rs 62,432 crore, says Equir...
- Market rally ahead? Earnings revival, PSU banks & NBFCs in focus, says InCred’s Aditya SoodIndia’s market is entering a new earnings-led cycle, says InCred AM’s Aditya Sood. With Nifty earnings expected to grow 10–12% and midcaps ...
- Hospitals, CDMOs to lead pharma growth; generics face weak FY27, says JM Financial’s Amey ChalkeIndian healthcare is entering a new growth cycle, with hospitals and CDMO players expected to deliver strong 20% EBITDA CAGR, while large g...
- Sun Pharma stares at 8-10% profit risk amid 100% Trump tariffs, says HSBC. Can the giant navigate this?Sun Pharma faces potential impact from the US 100% tariff on patented drugs, which could reduce FY26–27 earnings by 8–10%. Generic drugs re...
- Diamond player Shree Ramkrishna Exports forays into pharma businessShree Ramkrishna Exports, a prominent natural diamond company, has ventured into the pharmaceutical industry with the launch of Kriam Pharm...
- Macquarie sees potential upside in Indian pharma and CDMO stocksMacquarie is optimistic about Indian pharma and CDMO companies, predicting significant upside potential due to recent market corrections an...
- China’s India headache: The growing pharmaceutical industryIndian CDMOs are strategically expanding through acquisitions in the US and Europe, driven by global pharma's nearshoring trend and a desir...
- US tariffs will have minimal impact on Indian pharma service companies like CDMOs: ReportExporters can pass on cost increases to consumers, and the favourable USD/INR exchange rate and increased outsourcing opportunities are exp...
- India's CDMO market set to double by 2028 amid Asia's healthcare boomIndia's CDMO market is set to grow from USD 7 billion to USD 14 billion by 2028. This growth is driven by its strong stance in API manufact...
- India could account for 8-10 pc of work share outsourced to CDMOs by 2033: ReportIndia could take 8-10% of the global outsourcing share for Contract Research Development and Manufacturing Organisations by 2033 due to wor...
- Odisha asks medical colleges, CDMOs to increase surveillance, testing for potential COVID-19 surgePublic Health Director Niranjan Mishra in a letter to all medical colleges and CDMOs said: "The recent rise in COVID-19 cases across India ...
- Indian drug manufacturers benefit from Big Pharma interest beyond ChinaChina has for nearly 20 years been the preferred location for a range of pharmaceutical research and manufacturing services due to the low ...
- Covid cases: Mock drill at Delhi govt hospitals on Sunday to check preparedness"All the MS/MDs and CDMOs of all the hospitals of Delhi government are hereby requested to hold a mock drill on 26.03.2023 (Sunday) to chec...
- Centre to hold series of webinars on aspects of clinical management of Covid cases"The growing trajectory of COVID-19 cases and Variant of Concern (VOC) Omicron, in some of the states and Union Territories in the country ...
- Arvind Kejriwal hails Covid warriors as first dose of vaccine given to all eligible people in DelhiAccording to the CoWIN dashboard, 1,48,27,546 people in Delhi have taken at least one shot of COVID-19 vaccine by 8 pm on Thursday.
- Private hospitals in Delhi directed to accept cheques, draftsGovernment has also instructed the Chief District Medical officers (CDMOs) to inspect the private hospitals and nursing homes in their juri...
Load More
